Kona Medical, Inc. is a privately held company founded in 2009 and that has developed an innovative and non-invasive therapy for the treatment of hypertension (high blood pressure) and other disorders. Kona Medical is based in Bellevue, Washington and is actively supported by leading medical technology investors. The Surround Sound® Hypertension Therapy System provides a one-time, non-invasive procedure to treat hypertension using ultrasound imaging to robotically guide the delivery of focused ultrasound energy for renal denervation (RDN). The procedure eliminates the need for radiation, contrast media, shielding or cath lab and reduces cost and complexity compared to technologies. Clinical trials to date have shown promise in significantly reducing blood pressure with this simple procedure and provide an excellent safety profile.

The first clinical application of the Surround Sound system addresses severe high blood pressure (hypertension) through ablation of the renal nerves. Renal nerves are part of the sympathetic nervous system and play a significant role in determining blood pressure. Renal nerves are located adjacent to the renal arteries, which provide blood flow to the kidneys. Clinical research has shown that ablation of renal nerves may result in profound and lasting reduction in hypertension in patients whose blood pressure is not adequately controlled by medication.

Kona Medical’s proprietary technology enables non-invasive treatment for drug-resistant hypertension and has significant potential advantages over alternative methods.

CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use.